US FDA's Patient Experience Data Guidance Calls More Attention To Burdens Of Surveys

 
• By Sue Sutter
Focus lens
An FDA PFDD final guidance puts more focus on the accessibility and burden of quantitative data collection for patients. • Source: Alamy

More from R&D

More from Pink Sheet